The role of the cell surface molecules CD3 and LFA-I in exocytosis of cytotoxic granules and target cell cytolysis by CIK cell subpopulations has been investigated in an effort to better understand the mechanism of CIK cell-mediated cytotoxicity.
release of cytoplasmic granular contents from stimulated CTL is measured by release of the enzyme N-a-benzylcarbonyl-L-lysine thiobenzyl ester (BLT) esterase, which is a marker for granzymes with trypsin-like specificity present in the gran~les. 4 .~ The mechanism of target cell destruction includes the vectorial exocytosis into the intercellular space of cytoplasmic granular contents by the effector cell at the site of target cell Lytic potential has been shown for perforin; granzymes A and B participate in the induction of apopt~sis.~-~ Cytokine-induced killer (CIK) cells are highly efficient cytotoxic cells with enhanced proliferative capacity as compared with NK cells." These cells are generated by culturing peripheral blood mononuclear cells in the presence of interferon-y (IFN-y), monoclonal antibody (MoAb) against the CD3 surface antigen, interleukin-l (IL-l), and IL-2. These cells mediate highly efficient non-major histocompatibility complex (MHC)-restricted killing of tumor cell targets and proliferate rapidly in vitro." The greatest lytic activity in CIK cell cultures is found in the population of cells coexpressing CD3 and CD56. CIK cells do not express the CD16 (Fc receptor) surface molecule and, therefore, do not participate in antibody-dependent cellular cytotoxicity. The CD3+/ CD56' cell subpopulation is derived from T cells." The cytotoxic effects of CIK cells against tumor cell targets are blocked by antibodies against the adhesion receptor leukocyte function associated antigen-l (LFA-l) and its counter receptor, intercellular adhesion molecule-l (ICAM-l)." Activation of T lymphocytes through the T-cell receptor (TCR) results in the conversion of LFA-1 from a low-avidity to high-avidity state for binding to ICAM-l. This process involves transmission of intracellular signals from the TCR to LFA-1 that are inhibited by the addition of dibutyryl cyclic adenosine monophosphate (db-CAMP), a cell-permeable analog of CAMP, and agents that increase cytosolic cAMP levels. '3 The immunosuppressive drugs cyclosporine A (CsA) and FK506 inhibit T-cell signal transduction, which leads to inactivation of specific transcription factors involved in expression of lymphokines such as IL-2.'"I6 The intracellular receptors for these drugs are cyclophilins for CsA and FK506 binding proteins (FKBPs) for FK506, collectively known as immunophilins. 17 The complexes of CsA bound to cyclophilins and FK506 bound to FKBP can bind to and inhibit the activity of the calcium-regulated phosphatase calcine~rin.'~.'~~'"'~ A role for calcineurin has been proposed in degranulation of murine CTL.*O In this report we have studied the effects of db-CAMP, CsA, and FK506 on CIK cell degranulation and cytotoxicity towards a sensitive B-cell lymphoma target cell line, OCI-Ly8. The role of the cell surface molecules CD3 and LFA-I in exocytosis of cytotoxic granules and target cell cytolysis by CIK cell subpopulations has been investigated in an effort to better understand the mechanism of CIK cell-mediated cytotoxicity. Spontaneous release was the BLT esterase activity released from the effector cells in the absence of stimulatory agents and the maximal release was the activity in 1 % Nonidet-P 40 (Sigma) lysates of the cells.
EXPERIMENTAL PROCEDURES

Materials
Cytotoxicity assay. The cytotoxic potential of CIK cells was measured by "Cr release, as a measure of target cell lysis, and by ['H] thymidine release as a measure of target cell DNA degradation:' from appropriately labeled target cells.
"Cr release assay. Target cells (OCI-Ly8 and JY) were metabolically labeled with "Cr (Dupont-New England Nuclear, Boston, MA) by incubating 1 X IO6 cells with 300 pCi "Cr at 37°C for 1.5 hours. The labeled cells were washed three times with PBS containing 0.1 % bovine serum albumin (BSA) (Sigma) and distributed in flat-bottomed microtiter plates at a concentration of 2 X IO4 cells/ well. Effector cells (CIK and AJY-CTL) or CIK cell cytoplasmic granules were added at the indicated ratios or dilution, respectively.
MoAb against CD3 or LFA-I (10 pg/mL) were added before the addition of effector cells and incubated for 30 minutes at room temperature. After 4 hours at 37°C the cells were centrifuged and an aliquot of the supernatant was counted in a gamma counter (Micromedic Systems, Horsham, PA). The percentage of specitic "Cr release was calculated as above. Spontaneous release waq obtained by incubating the labeled cells in complete medium alone and maximal release by treatment of the cells with 1%' NP-40.
['HI thymidine release. Target cells ( 1 to 2 X 10") were incubated in complete RPM1 medium containing 0. I mCi of ['H] thymdine (Dupont-New England Nuclear) for 20 hours at 37°C to label the DNA. Cells were washed and resuspended in complete RPMI medium. CIK cells were added at a ratio of 20: I to 2 X 10' labeled OCI-LyS cells in flat-bottomed 96-well plates and incubated for 4 hours at 37°C. The cells were then lysed by adding lysis buffer consisting of 0.2% Triton-X-100 in PBS. The plate was centrifuged at 500g for 15 minutes. The radioactivity in the supernatant was measured in a scintillation counter. Co. Santa Clara, CA) equipped with a FACS-DESK software (Becton Dickinson). Background staining using an isotype-matched irrelevant antibody plus second-stage reagent was less than 2%. Cells were reanalyzed after sorting and tested as effector cells in the assays.
Isolation of cytoplasmic granulrs. Cytoplasmic granules from CIK cells were isolated using the method described for isolation of human lymphokine-activated killer (LAK) cell-derived granules.' CIK cells (1 X 10") were washed in PBS, resuspended in 12 mL PIPEG (100 mmol/L KCI, 3.5 mmol/L NaCI, 3.5 mmol/L MgClz. I mmol/L adenosine triphosphate, 1.25 mmol/L EGTA, and I O mmol/L PIPES, pH 6.8) and the cell membranes ruptured by sonication. The nuclei were removed by centrifugation at 1,0001: for I O minutes. The organelles were separated on a discontinuous percoll gradient (Sigma) consisting of 15.9 mL of 85% (vol/vol) percoll. and 12. I mL of 39% percoll in PIPEG. The tube was centrifuged at 43,6708 (rotor model JA20; Beckman Instruments. Palo Alto. CA) for 30 minutes at 4°C. One-milliliter fractions were collected and tested for BLT esterase activity. Active fractions were pooled and ultracentrifuged at 180,000g (rotor model SW41; Beckman Instruments) for 2 hours at 4°C to eliminate percoll. The supematant containing the granules was recovered and used for testing cytolytic activity against "Cr labeled OCI-Ly8 target cells. The fractions that did not exhibit BLT esterase activity were also pooled, ultracentrifuged to remove percoll and used as a control in the assay for cytolysis The CIK cells and AJY-CTL, which were stimulated with MoAb against CD3, showed 68% and 65% specific release of BLT esterase, respectively (Fig 1) . Stimulation of both cell types with plate-bound MoAb against LFA-l did not result in significant release of BLT esterase from either. Cross-linked CD3 MoAb (coated on the well surface) was required for stimulating BLT esterase release from CIK and AJY-CTL cells as soluble CD3 MoAb was ineffective (data not shown).
RESULTS
Cross-linked
MoAbs against LFA-l but not against CD3 inhibit cytotoxicity of CIK cells against target cells. CIK cells efficiently lyse OCI-Ly8 target cells (Table 1) . CIK cell mediated cytolysis of OCI-Ly8 cells was inhibited by 84% after addition of MoAb against LFA-1. However, MoAb against CD3 did not have a significant effect on CIK cytotoxicity against the OCI-Ly8 cells. The killing of JY cells by AJY-CTL was inhibited by 79% in the presence of CD3 MoAb, whereas MoAb against LFA-1 caused an inhibition of 37% (Table  1) . The cytotoxic capacity of CIK cells was significantly reduced after the cells had undergone degranulation with CD3 MoAb (data not shown).
To directly assess the cytotoxic capacity of granule contents, CIK cell cytoplasmic granules were isolated using density gradient ultracentrifugation. Fractions that exhibited BLT esterase activity were pooled and tested for cytolytic activity against 5'Cr-labeled OCI-Ly8 cells. The granule fractions with BLT esterase activity were capable of lysing OCI-Ly8 cells (maximally 64.2 f 1.8% "Cr release). The cytolytic activity could be progressively diminished with increasing dilution of the active fraction.
The CD3+CD56+ subpopulation of CIK cells exhibits maximum BLT esterase release and cytotoxicity toward target cells. CIK cells were stained with MoAb against CD3 conjugated with FITC and CD56 conjugated with PE. Although variable from one experiment to the next, in most instances, approximately 75% of the total cells were CD3+CD56-, whereas 25% coexpressed CD3 and CD56.
The stained cells were sorted into CD3+CD56-and CD3+CD56+ populations, which were greater than 90% pure. Treatment of the CIK cells with the fluoresceinated anti-CD3 MoAb did not induce degranulation because the MoAb was directly conjugated with the dye, thereby avoiding cross-linking of the MoAb that is necessary for BLT esterase release from CIK cells.
The subpopulations were tested for BLT esterase release. The CD3+CD56+ cell population was found to release maximum BLT esterase upon stimulation with cross-linked MoAb against CD3 (Fig 2) . There was significantly less release of BLT esterase by the unsorted CIK cells (29. OCI-Ly8 cells were also used to stimulate granule release (Fig 3) . When the CIK cell populations were stimulated with OCI-Ly8 cells instead of cross-linked CD3 MoAb, maximum BLT esterase was again observed to be released from the CD3+CD56' cells (data not shown). The addition of MoAb against LFA-l did not have any effect on the tumor cell--induced release of cytotoxic granule contents.
The CIK cell subpopulations were tested for cytotoxicity against the OCI-Ly8 cells as measured by "Cr release. As has been previously reported,'* the maximum cytolytic activity was expressed by the CD3+CD56' cells. An alternate method of evaluating the potential of cytotoxic cells is by measurement of the breakdown of DNA in the target cells. The CD3+CDS6+ population also caused maximum degradation of target cell DNA as compared with the CD3TD56" cells and the unsorted CIK cells ( Table 2) .
Effect of db-CAMP on degranulation and cytotoxicity of CIK cell populations. db-CAMP is a cell permeable analog of CAMP. The CIK cell populations treated with db-CAMP were tested for cytotoxicity (51Cr and ["]-thymidine release) against OCI-Ly8 cells. Treatment with db-CAMP resulted in an inhibition in target cell killing by unsorted CIK cells by 38% and of the CD3+CD56+ cells by 48% (Table 2 ). There was no significant change in the cytotoxicity of the cells in the presence of CAMP, which cannot enter the cell and served as a control in these experiments. In addition, we observed a significant inhibition in the capacity of CIK cell MEHTA ET AL populations in degrading OCI-Ly8 cell DNA in the presence of db-CAMP (Table 2) .
The release of BLT esterase from unsorted CIK cells stimulated with CD3 MoAb was dramatically reduced by addition of db-CAMP (Fig 3) . A complete inhibition of degranulation was also observed using the CD3ICD56' and the CD3+CDS6 cell populations treated with db-CAMP (data not shown). The cell-impermeable CAMP was again used as a control and was found to have no or minimal effect on degranulation from the different cell populations. When OCI-Ly8 target cells were used to induce target cell degranulation, near complete inhibition was observed when db-CAMP was added (Fig 3) .
C'sA and FK506 prevent CIK cell degranulation when stirnuluted by CD3 MoAb, but not by turget cells. Treatment of CIK cells and AJY-CTL with the immunosuppressive drugs CsA (100 ng/mL) and FKS06 (2 ng/mL) resulted in a dramatic inhibition of BLT esterase release when the effector lymphocytes were activated with cross-linked anti-CD3 MoAb (Fig 3) . Complete inhibition of BLT esterase release from the CIK cells was observed in the presence of FKS06, and a 90% inhibition in the presence of CsA. A similar inhibition was observed using CD3+CDS6+ cells or AJY-CTL treated with the immunosuppressive drugs (data not shown).
In striking contrast, there was no inhibition in degranulation of CIK cells by treatment with CsA or FK506 when the cells were stimulated with OCI-Ly8 cells instead of crosslinked CD3 MoAb (Fig 3) . Treatment of CIK cells with the immunosuppressive drugs caused a partial inhibition of cytotoxicity against the OCI-Ly8 cells at a low effector:target (E:T) ratio of 2: 1. There was no effect of treatment with the drugs on CIK cell cytolysis of target cells at E:T ratios of S: I and 1O:l (Fig 4) .
DISCUSSION
In this study we have investigated the mechanism of cytotoxicity of CIK cells, which proliferate more rapidly than LAK cells and have been observed to have enhanced in vivo anti-lymphoma effects using mice with severe combined immunodeficiency injected with human lymphoid tumor ceIIs."."
Our results indicate that cross-linked MoAb against CD3 In this study, treatment of CIK cells with db-CAMP resulted in a dramatic inhibition of BLT esterase release and a less dramatic but significant inhibition of cell-mediated cytotoxicity by the CIK cells. Inhibition of CD3 MoAb or target cell-induced cytoplasmic granule release was complete in the presence of db-CAMP, whereas inhibition of cytotoxicity as measured by 51Cr release or ['H]-thymidine release was significant but not complete. A possible explanation for this observation could be that alternative mechanisms of cytotoxicity, which are independent of cytotoxic granule contents and intracellular cAMP levels, were operat i~e .~. *~ One of the candidate molecules that is known to mediate Ca2'-independent target cell DNA breakdown is the surface protein fa^.'^.^'
Our observations indicate that secondary messengers such as cAMP can be involved in regulating exocytosis and killing of target cells by the CIK cells, and that similar mechanisms of cytotoxicity could be operative in activation of CTL and CIK cells. The induction of BLT esterase release from CIK cells upon activation with MoAb against CD3 also suggests that the surface molecules involved in activation of CTL and CIK cells may operate through at least one common pathway that causes granule release. Because CIK cells recognize target cells through a non-MHC-restricted mechanism, the cellular receptors that stimulate granule release after cellular stimulation may function in a similar manner to activation of the TCR in CTL. These data suggest that even though the mechanisms of target cell recognition by CIK cells and CTL are distinct, at least one of the cellular mechanisms required for cytotoxic granule release from the two effector cell types is similar.
The mechanism of exocytosis of cytoplasmic granules leading to cytolysis of the target cell is not yet completely understood. It has been observed that stimulation of the TCR in murine T-helper cells and T-cell clones induces colocalization of LFA-I and the cytoskeletal protein talin into the contact region of the T cell with an antigen presenting ce11.28.2y Colocalization of LFA-1 and talin has also been observed in other cell couples such as the NK cel1:target cell and CTL:target cell couples. One of the proposed functions of talin redistribution in the effector cell is the stabilization of intercellular adhesion through LFA-1 to allow for the interactions that lead to directed exocytosis of effector cell secretory vesicles. Other cytoskeletal proteins such as microfilaments, represented by actin, and microtubules, consisting mainly of tubulin, are also known to be important during the various stages of T-and NK-cell-mediated cytot~xicity.~~ Integrins such as LFA-l can interact with actin microfilaments via talin and vinculin proteins and are observed to rearrange from a diffuse cytoplasmic distribution to a marginal localization upon conjugate formation between effector and target cells.'0.'' Normal microtubule function has been shown to be necessary for the release of cytotoxic factors present in the cytoplasmic granules of NK and LAK effector cells." It has been reported that triggering of the TCR in mature CTL induces an accumulation in cAMP levels that interferes with cytoskeletal function and results in termination of CTL secretion and adhesion to the target cell, and could also play a role in CTL motility." The role of cytoskeleta1 elements such as actin, tubulin, and talin in CIK-cellmediated cytotoxicity is currently under study.
The immunosuppressive drugs CsA and FK506 inhibit a number of T-cell responses dependent on new protein synthesis such as TCR-induced lymphokine transcription and proliferation of T cells as well as activation-induced death in T-cell hybridomas and thymo~ytes.'~.""~ The immunosuppresents can block T-cell functions by inhibiting the calciumdependent serinelthreonine phosphatase calcineurin.14~16.'8~20 These drugs have also been shown to inhibit BLT esterase release from murine CTL, a process that does not require protein synthesis.20
The CD3+CD56+ cell subpopulation in CIK cell cultures with the greatest cytotoxic potential, is derived from T cells." It was observed that the immunosuppressive drugs CsA and FK506 completely inhibit BLT esterase release from CIK cells and CD3TD56' cells stimulated with crosslinked CD3 MoAb, suggesting that the CD3-linked degranulation pathway is intact in CIK cells.
Interestingly, when CIK cells were stimulated with cogFor personal use only. on October 3, 2017. by guest www.bloodjournal.org From nate OCI-Ly8 target cells instead of CD3 MoAb to release BLT esterase, the immunosuppressive drugs did not have any effect on their degranulation. This observation strongly suggests that an alternate pathway of degranulation in CIK cells, which is not affected by CsA and FKS06, is operative in the presence of target cells, unlike the CD3-linked pathway. The cellular receptors that are involved in triggering this pathway are yet to be identified. This pathway could be responsible for the observation that there was no significant inhibition of CIK cell cytolysis of OCI-Ly8 cells in the presence of the immunosuppressive drugs. Another possibility is that the immunosuppressive agents may be responsible for inhibiting effector cell recycling that can be manifested as an inhibition in cellular cytotoxicity at low E:T ratios which has also been observed by others in case of CTL. 33 Other investigators have reported that target cell lysis by murine CTL is not inhibited in the presence of CsA, FKS06, or rapamy~in.'"~~'.~' This was attributed to the existence of Cazf-independent and degranulation-independent pathways of killing by CTL, or to residual BLT esterase activity in the presence of these drugs, which may be sufficient to account for the cytolytic activity.
We propose two pathways by which CIK cells can kill target cells. The first pathway, stimulated by CIK recognition structures in concert with LFA-I leads to a granule-dependent cytolysis. This pathway is sensitive to increased intracellular cAMP levels and is resistant to the immunosuppressive drugs CsA and FKS06. The second pathway, which proceeds through stimulation of CD3 or CD3-like surface receptors on CIK cells, leads to granule-mediated killing that is sensitive to increased intracellular cAMP levels, CsA and FKS06. The first pathway is usually the dominant one and accounts for CIK cell cytotoxicity against OCI-Ly8 target cells mediated by CIK recognition structures. Both pathways involve exocytosis of cytoplasmic granule contents, indicating that this may be the main mechanism by which CIK cells kill their targets. Identification of the putative CIK receptors for tumor cell targets as well other cell surface molecules involved in these cytotoxicity mechanisms will be extremely useful for further understanding of non-MHCrestricted lymphocyte cytotoxicity against tumor cells.
